2Bistrian BR. Interaction between nutrition and inflammation in endstagerenal disease [ J]. Blood Purif, 2000,18 (4) : 333 - 336.
3Paniehi V, Migliori M, Pietro D, et al. Plasma C-reactive protein in hemodialysis patients : A cross-sectional, longitudinal clinical survey [ J]. Blood Purif,2000,18 ( 1 ) :30 - 36.
4Arici M, Walls J. Endstage renal disease, atherosclemsis, and cardiovascular mortality: Is C-reactive protein the missing link? [ J]. Kidney Int,2001,59(2) :407 -414.
5Mcintyre C, Harper I, Macdougall IC,et al. Serum C-reactive protein as 22a marker for infection and inflammation in regular dialysis patients [ J ]. Clin Nephrol, 1997,48 (6) :371 - 374.
6Jadoul M, Cornu C, Van Ypersele de Strihou C, et al.Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study [ J ]. Kidney Int, 1993,44:1322 - 1325.
7Sarnak M J,Jaher BL.Pulmonarv infectious mortality aaong patients with end-stage renal disease[J].Chest,2001,120(6):1 883 ～ 1 887.
